Deutsche Bank Aktiengesellschaft Downgrades 10x Genomics (NASDAQ:TXG) to Hold

10x Genomics (NASDAQ:TXG – Get Free Report) was downgraded by stock analysts at Deutsche Bank Aktiengesellschaft from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday, MarketBeat.com reports. They presently have a $25.00 target price on the stock, down from their previous target price of $55.00. Deutsche Bank […]

Leave a Reply

Your email address will not be published.

Previous post Citigroup Downgrades Glaukos (NYSE:GKOS) to Neutral
Next post Aston Martin: Sensational Hypercars Double Down For Le Mans Glory